At Lightpoint, we are optimizing the performance of minimally-invasive and robotic cancer surgery, by developing miniaturized imaging and sensing tools to accurately detect cancer intra-operatively. The aims of the tools are to aid surgical decision making, improve patient outcomes and save costs for healthcare system.

Enhancing surgical precision

Lightpoint has a pipeline of miniaturized tools in development. The technologies incorporate recent advances in miniaturized sensors and detect cancer-targeted drugs already validated for whole-body imaging, such as SPECT/PET scans. The miniaturized probes aim to accurately identify cancer, enabling the full removal of diseased tissue, or confirm its absence, helping to preserve healthy, functional tissue. SENSEI® is our first robotic probe. Find out more in the video below.

Lightpoint Medical, Ltd Videos

Lightpoint Medical robotic probe SENSEI - Video